Literature DB >> 2544260

Adriamycin activation and oxygen free radical formation in human breast tumor cells: protective role of glutathione peroxidase in adriamycin resistance.

B K Sinha1, E G Mimnaugh, S Rajagopalan, C E Myers.   

Abstract

Previous studies with Adriamycin-sensitive and -resistant (ADRR) MCF-7 human breast tumor cell lines indicated that Adriamycin formed significantly less hydroxyl radical (.OH) as the result of enhanced detoxification of reactive oxygen intermediates in the ADRR cell line. In order to further define the sites of drug activation and the role of detoxification mechanisms in free radical levels, subcellular fractions were isolated from these two cell lines and free radical formation in the presence of Adriamycin was examined by using electron spin resonance spectroscopy. Studies reported here show that considerable NADPH-cytochrome P-450 reductase and NADH dehydrogenase activities were present in microsomes and mitochondria, respectively, and in nuclei obtained from these cells, and the relative activity of NADH dehydrogenase was 2-fold higher in the mitochondrial fraction of ADRR cells compared to the mitochondrial fraction from the parental wild type cells. In the presence of Adriamycin and a reducing cofactor (NADPH or NADH), Adriamycin semiquinone free radical, superoxide anion, and .OH were detected in all these fractions. Although only a small difference in the relative amount of oxy radical formation was detected in tumor microsomes, both mitochondria and nuclei of ADRR cells showed an overall 2-fold decreased formation of oxy radicals. The formation of the free radicals was significantly inhibited by superoxide dismutase, catalase, and dimethyl sulfoxide, indicating that free .OH generation was both superoxide and hydrogen peroxide dependent. The addition of purified glutathione peroxidase likewise inhibited .OH formation in a dose-dependent fashion. Similarly, when the lysate from ADRR cells, which contains 12- to 14-fold more glutathione peroxidase than Adriamycin-sensitive cells, was added to reaction mixtures containing Adriamycin-sensitive cells and Adriamycin, the .OH formation was diminished. Decreased free radical formation in nuclei and mitochondria, as a result of detoxification of hydrogen peroxide by glutathione peroxidase, may be significant in the protection of ADRR cells from Adriamycin-induced cell killing.

Entities:  

Mesh:

Substances:

Year:  1989        PMID: 2544260

Source DB:  PubMed          Journal:  Cancer Res        ISSN: 0008-5472            Impact factor:   12.701


  37 in total

1.  Cytotoxicity of doxrubicin loaded single-walled carbon nanotubes.

Authors:  Ayhan Ünlü; Mehdi Meran; Bircan Dinc; Nilgün Karatepe; Muhammet Bektaş; F Seniha Güner
Journal:  Mol Biol Rep       Date:  2018-05-24       Impact factor: 2.316

2.  Members of the glutathione and ABC-transporter families are associated with clinical outcome in patients with diffuse large B-cell lymphoma.

Authors:  Charalambos Andreadis; Phyllis A Gimotty; Peter Wahl; Rachel Hammond; Jane Houldsworth; Stephen J Schuster; Timothy R Rebbeck
Journal:  Blood       Date:  2006-12-19       Impact factor: 22.113

3.  Chrysin enhances doxorubicin-induced cytotoxicity in human lung epithelial cancer cell lines: the role of glutathione.

Authors:  Heather M Brechbuhl; Remy Kachadourian; Elysia Min; Daniel Chan; Brian J Day
Journal:  Toxicol Appl Pharmacol       Date:  2011-08-10       Impact factor: 4.219

4.  Oxidant-antioxidant status in colorectal cancer patients-Before and after treatment.

Authors:  Sharmila Upadhya; Subramanya Upadhya; S Krishna Mohan; K Vanajakshamma; Mamatha Kunder; Seema Mathias
Journal:  Indian J Clin Biochem       Date:  2004-07

5.  Nitric oxide: Friend or Foe in Cancer Chemotherapy and Drug Resistance: A Perspective.

Authors:  Birandra K Sinha
Journal:  J Cancer Sci Ther       Date:  2016-10-28

6.  The differential gene expression profiles between sensitive and resistant breast cancer cells to adriamycin by cDNA microarray.

Authors:  Myung-Ju Ahn; Ki-Hwan Lee; Joon-Ik Ahn; Dong-Hyun Yu; Hye-Sook Lee; Jung-Hye Choi; Joung Soon Jang; Jong Min Bae; Yong-Sung Lee
Journal:  Cancer Res Treat       Date:  2004-02-29       Impact factor: 4.679

7.  Unexpected hormonal activity of a catechol equine estrogen metabolite reveals reversible glutathione conjugation.

Authors:  Kuan-Wei Peng; Minsun Chang; Yue-Ting Wang; Zhican Wang; Zhihui Qin; Judy L Bolton; Gregory R J Thatcher
Journal:  Chem Res Toxicol       Date:  2010-08-16       Impact factor: 3.739

8.  Pro-oxidant and antioxidant effects of N-acetylcysteine regulate doxorubicin-induced NF-kappa B activity in leukemic cells.

Authors:  Nnenna Adimora Finn; Melissa Lambeth Kemp
Journal:  Mol Biosyst       Date:  2011-12-01

Review 9.  Iron chelators with topoisomerase-inhibitory activity and their anticancer applications.

Authors:  V Ashutosh Rao
Journal:  Antioxid Redox Signal       Date:  2012-10-26       Impact factor: 8.401

10.  RNAi-mediated silencing of nuclear factor erythroid-2-related factor 2 gene expression in non-small cell lung cancer inhibits tumor growth and increases efficacy of chemotherapy.

Authors:  Anju Singh; Swetlana Boldin-Adamsky; Rajesh K Thimmulappa; Srikanta K Rath; Hagit Ashush; Jonathan Coulter; Amanda Blackford; Steven N Goodman; Fred Bunz; Walter H Watson; Edward Gabrielson; Elena Feinstein; Shyam Biswal
Journal:  Cancer Res       Date:  2008-10-01       Impact factor: 12.701

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.